Form 4: ArriVent BioPharma COO Robin LaChapelle Reports Stock Option Exercises and Share Ownership Changes
SEC Form 4 Filing
Robin LaChapelle, Chief Operating Officer of ArriVent BioPharma, reports exercising stock options and changes in beneficial ownership of common stock.
Summary
- On September 19, 2024, Robin LaChapelle, the Chief Operating Officer of ArriVent BioPharma, executed multiple transactions involving ArriVent BioPharma's common stock.
- LaChapelle exercised stock options to acquire a total of 27,566 shares of common stock at prices of $2.28, $3.65, and $6.24 per share.
- Following these transactions, LaChapelle directly owns 124,583 shares of ArriVent BioPharma common stock.
- Additionally, LaChapelle is deemed to have indirect beneficial ownership of 394,477 shares held by The MAKS Yao Trust, for which LaChapelle serves as trustee but disclaims pecuniary interest.
- LaChapelle also holds various stock options with exercise prices of $2.28, $3.65 and $6.24, with varying vesting schedules and expiration dates.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently indicate positive or negative performance.
Positives
- The exercise of stock options by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- Shareholders are informed about changes in insider ownership, which can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/08/2022 | 25% of shares underlying one stock option vested. |
| 02/01/2023 | 25% of shares underlying two stock options vested. |
| 02/01/2024 | 25% of shares underlying one stock option vested. |
| 08/22/2024 | 25% of shares underlying one stock option vested. |
| 09/19/2024 | Date of stock option exercises and reported transactions. |
| 09/23/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.